| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |